NL-OMON33777已完成不适用
Role of neutralizing (maternal) antibodies in protection against human parechovirus infection and other risk factors for picornavirus infection in young children. - Role of antibodies in human parechovirus infection in young children.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 216
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •Infants under the age of 1 year, positive for HPeV in CSF, stool, nasopharynx and/or blood obtained for diagnostic purposes and detected by routine PCR.
- •Controls under the age of 1 year will be randomly selected from the diagnostic CSF, stool, nasopharynx and/or blood samples positive for EV PCR and negative for EV/HPeV PCR, and matched for age.
- •The mothers of those infants.
- •Written informed consent.
排除标准
- •No informed consent
研究者
相似试验
尚未招募
4 期
A study on the maternal and infant factors determining the performance of Rotavirus vaccines in African, Indian and European infants.CTRI/2015/11/006354Christian Medical College385
招募中
不适用
Immune profile of PIMS-TSCTRI/2021/01/030605IHNIRTICER
招募中
不适用
Identification of neutralizing antibodies against severe or chronic infections of human beingDRKS00010169niversitätsklinikum Köln1,000
进行中（未招募）
1 期
Induction of Cross-neutralizing Antibodies After Primary Vaccination With Two Different Tick- borne Encephalitis Virus VaccinesThe study is exploring the cross neutralizing potential of human sera after primary immunization with FSME-IMMUN 0.5 ml or Encepur 0.5 ml against different strains within the same TBEV subtype, other TBEV subtypes, closely related viruses of the TBEV serogroup, and also more distantly related flaviviruses, based on the use of a hybrid virus assay platformEUCTR2016-003124-23-ATMedical University of Vienna, ISPTM60
已完成
4 期
The response of vasculitis patients to influenza vaccination compared to healthy individualsACTRN12608000440325Royal Adelaide Hospital100